ArticleOncology research2025

SIK2 inhibitor SIC-19 enhances the sensitivity of PARP inhibitors in triple-negative breast cancers and pancreatic cancers.

Qian Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.